$750 Million Ketamine Drug Market Withing Reach via New Commissioner's National Priority Vouchers with Anticipated Approval by Year-End for NRx 
NUFABRX awarded Therapeutic Compression agreement with Premier, Inc 
TKSoftware Inc. Unveils ICONIC Pro: The All‑In‑One Medical Billing & Clearinghouse Solution 
Carlonoscopen Launches Base-Zero Number System — A New Mathematical Language for Tomorrow's Tech 
Speranza Dental Implant Centers Opens Their First Location 
Profiting from Elder Harm: The Push to End Psychiatric Drugging in Nursing Homes 
Dr. Jacqueline West Honored as Best Dentist in JAX by Folio Weekly 
Exciting News: Pivotal Health Solutions Acquires Revolutionary Portable Parallel Bars 
Mensa Foundation Prize Awarded to Neuroscientist-Pianist 
purelyIV Blog Named One of the Top 45 IV Therapy Blogs by Feedspot 
purelyIV Launches Mobile Iron Infusion Therapy for Patients with Iron Deficiency Anemia 
Smile Makers Dental Care Introduces FP1: East Bay's First Robotic-Assisted Full-Arch Implant Solution for Natural, Fixed Smiles 
Global Court Momentum Builds Against Forced Psychiatry; CCHR Urges U.S. Reform 
Experience Trembling Firsthand with the New AgeMan® Tremor Simulator 
Urgent Reform Demanded to Stop Child Abuse in Youth Behavioral Facilities 
Kaplan Morrell Applauds Passage of Landmark Workers' Compensation Reform in Colorado $750 Million Market Projected to Reach $3.3 Billion Globally in 2034 for New Drug Application Filed on Preservative-Free IV Ketamine: NRx Pharma, Inc 
oneservice AG Names Andrea Steudel as CFO to Drive Global Growth and Financial Transformation 
June 2-8 is Medicare Fraud Prevention Week 
CCHR Warns: Millions of Children Exposed to Risky Psychiatric Drugs